Study of URG101 in Painful Bladder Syndrome and Interstitial Cystitis
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
A double-blind, placebo-controlled study to evaluate changes in pain, urgency and urinary
frequency following administration of URG101 compared to placebo.